Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Asmussen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Urology|March 1, 1997
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer GroupP Iversen, F Rasmussen, C Asmussen, et al.
The Patient|June 28, 2018
The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic DiseasesTanja S Jørgensen, Marie Skougaard, Peter C Taylor, et al.
Nature Aging|December 10, 2024
IL-23R is a senescence-linked circulating and tissue biomarker of agingChase M Carver, Sonia L Rodriguez, Elizabeth J Atkinson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 22, 2025
The Sixth Annual Symposium of the Midwest Aging ConsortiumInes Sturmlechner, Sarah A Ashiqueali, Hélène Martini, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Urology|March 1, 1997
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer GroupP Iversen, F Rasmussen, C Asmussen, et al.
The Patient|June 28, 2018
The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic DiseasesTanja S Jørgensen, Marie Skougaard, Peter C Taylor, et al.
Nature Aging|December 10, 2024
IL-23R is a senescence-linked circulating and tissue biomarker of agingChase M Carver, Sonia L Rodriguez, Elizabeth J Atkinson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 22, 2025
The Sixth Annual Symposium of the Midwest Aging ConsortiumInes Sturmlechner, Sarah A Ashiqueali, Hélène Martini, et al.
Pageof 2